Is the new SARS-CoV-2 UK variant (B.1.1.7) already in the US? Maybe.
Since the onset of the COVID-19 pandemic, there has been concern about novel SARS-CoV-2 mutations emerging that are more transmissible. Recently, multiple novel strains of SARS-CoV-2 have been found to share the same deletion of...
5 ways Helix’s research community has advanced science in 2020
As we wrap up 2020 and look back at the year we’ve all endured, it’s important to highlight the places where humanity shone through the darkness. One such place is in our research community. While...
Helix Delivers One Millionth COVID-19 Test
Today, we’re excited to announce a major milestone – we’ve delivered 1,000,000 COVID-19 tests since we first launched our testing in late June. While we’ve been scaling rapidly since then, we’ve recently accelerated tremendously, with...
Helix survey data contributes to a new COVID-19 study
In a recent study, researchers from an international consortium used genetic data alongside survey responses to gain insight into how our DNA may affect our vulnerability to the SARS-CoV-2 virus (the virus responsible for the...
Managing COVID-19 outbreaks with screening & surveillance
Here, we describe how the use of COVID-19 screening and the combined use of screening results for surveillance can be an effective way to manage COVID-19 outbreaks under various conditions based on epidemiological modeling.
Update on COVID-19 research at Helix
Data from Helix's research community is helping scientists around the world, including a recent finding published in the New England Journal of Medicine.
Beyond the cough: symptoms and trends from a COVID-19 survey
Our team of researchers are currently working through the data, but we have already found some interesting insights in our collection of survey responses, and we’ve contributed our findings to a worldwide research effort, consisting...